A system for treating ischemic disease using human embryonic stem cell-derived endothelial cells without direct incorporation

Biomaterials

Volumn 32, Issue 27, 2011, Pages 6445-6455

  Moon, Sung Hwan ^a   Kim, Jong Soo ^b   Park, Soon Jung ^b   Lee, Hye Jin ^b   Do, Jeong Tae ^b   Chung, Hyung Min ^a,b  

^a CHA Stem Cell Institute   (South Korea)

^b CHA University   (South Korea)

Author keywords

Angiogenesis; Cell encapsulation; Endothelial cells; Implantation; Paracrine effect

Indexed keywords

ANGIOGENESIS; ANGIOGENIC FACTOR; CELL ENCAPSULATION; EMBRYONIC STEMS; ENCAPSULATION SYSTEMS; HIND LIMBS; HUMAN EMBRYONIC STEM CELLS (HESC); IN-VIVO; MOUSE MODELS; PARACRINE; REGENERATIVE MEDICINE; SIDE EFFECT; TECHNICAL SAFETY; THERAPEUTIC EFFECTS; TISSUE DAMAGE; TUMORIGENESIS;

AGGLOMERATION; BIOCHEMISTRY; CYTOLOGY; MAMMALS; STEM CELLS; TISSUE;

ENDOTHELIAL CELLS;

AMPUTATION; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL AGGREGATION; CELL MIGRATION; CELL SURVIVAL; CELL THERAPY; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; ENCAPSULATION; ENDOTHELIUM CELL; HINDLIMB; HUMAN; HUMAN CELL; IN VIVO STUDY; LIMB ISCHEMIA; MALE; MOUSE; NONHUMAN; PATIENT SAFETY; PRIORITY JOURNAL; TERATOMA; TISSUE INJURY;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; BLOOD CIRCULATION; CELL DIFFERENTIATION; CELL SURVIVAL; CULTURE MEDIA, CONDITIONED; EMBRYONIC STEM CELLS; ENDOTHELIAL CELLS; FIBROSIS; HINDLIMB; HUMANS; IMPLANTS, EXPERIMENTAL; ISCHEMIA; MALE; MICE; MICE, NUDE; MUSCLES; SPHEROIDS, CELLULAR; STEM CELL TRANSPLANTATION;

EID: 79960100457     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.05.026     Document Type: Article

References (41)

1. Cao F., Wagner R.A., Wilson K.D., Xie X., Fu J.D., Drukker M., et al. Transcriptional and functional profiling of human embryonic stem cell-derived cardiomyocytes. PLoS ONE 2008, 3:e3474.
2. Simons J.P., Goodney P.P., Nolan B.W., Cronenwett J.L., Messina L.M., Schanzer A. Failure to achieve clinical improvement despite graft patency in patients undergoing infrainguinal lower extremity bypass for critical limb ischemia. J Vasc Surg 2010, 51:1419-1424.
3. Pesce M., Orlandi A., Iachininoto M.G., Straino S., Torella A.R., Rizzuti V., et al. Myoendothelial differentiation of human umbilical cord blood-derived stem cells in ischemic limb tissues. Circ Res 2003, 93:e51-62.
4. Iba O., Matsubara H., Nozawa Y., Fujiyama S., Amano K., Mori Y., et al. Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation 2002, 106:2019-2025.
5. Kocher A.A., Schuster M.D., Szabolcs M.J., Takuma S., Burkhoff D., Wang J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001, 7:430-436.
6. Madeddu P., Emanueli C., Pelosi E., Salis M.B., Cerio A.M., Bonanno G., et al. Transplantation of low dose CD34+KDR+ cells promotes vascular and muscular regeneration in ischemic limbs. FASEB J 2004, 18:1737-1739.
7. Cho H.J., Lee N., Lee J.Y., Choi Y.J., Ii M., Wecker A., et al. Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart. J Exp Med 2007, 204:3257-3269.
8. Rehman J., Traktuev D., Li J., Merfeld-Clauss S., Temm-Grove C.J., Bovenkerk J.E., et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 2004, 109:1292-1298.
9. Zhang S.C., Wernig M., Duncan I.D., Brustle O., Thomson J.A. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 2001, 19:1129-1133.
10. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
11. Itskovitz-Eldor J., Schuldiner M., Karsenti D., Eden A., Yanuka O., Amit M., et al. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med 2000, 6:88-95.
12. Kim J., Moon S.H., Lee S.H., Lee D.R., Koh G.Y., Chung H.M. Effective isolation and culture of endothelial cells in embryoid body differentiated from human embryonic stem cells. Stem Cells Dev 2007, 16:269-280.
13. Cho S.W., Moon S.H., Lee S.H., Kang S.W., Kim J., Lim J.M., et al. Improvement of postnatal neovascularization by human embryonic stem cell derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia. Circulation 2007, 116:2409-2419.
14. Lee M.J., Kim J., Lee K.I., Shin J.M., Chae J.I., Chung H.M. Enhancement of wound healing by secretory factors of endothelial precursor cells derived from human embryonic stem cells. Cytotherapy 2011, 13:165-178.
15. Tzukerman M., Rosenberg T., Ravel Y., Reiter I., Coleman R., Skorecki K. An experimental platform for studying growth and invasiveness of tumor cells within teratomas derived from human embryonic stem cells. Proc Natl Acad Sci U S A 2003, 100:13507-13512.
16. Draper J.S., Smith K., Gokhale P., Moore H.D., Maltby E., Johnson J., et al. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol 2004, 22:53-54.
17. Moon S.H., Kim J.S., Park S.J., Lim J.J., Lee H.J., Lee S.M., et al. Effect of chromosome instability on the maintenance and differentiation of human embryonic stem cells in vitro and in vivo. Stem Cell Res 2011, 6:50-59.
18. Ahn J.S., Moon S.H., Kim J., Chung H.M., Kim J.K. Identification of differentially expressed genes in human embryonic stem cell-derived endothelial cells using suppression subtractive hybridization. Stem Cells Dev 2010, 19:1249-1256.
19. Levenberg S., Golub J.S., Amit M., Itskovitz-Eldor J., Langer R. Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A 2002, 99:4391-4396.
20. Dutrillaux B., Viegas-Pequignot E. High resolution R- and G-banding on the same preparation. Hum Genet 1981, 57:93-95.
21. Kim S., Kim G.J., Miyoshi H., Moon S.H., Ahn S.E., Lee J.H., et al. Efficiency of the elongation factor-1alpha promoter in mammalian embryonic stem cells using lentiviral gene delivery systems. Stem Cells Dev 2007, 16:537-545.
22. Di Santo S., Yang Z., Wyler von Ballmoos M., Voelzmann J., Diehm N., Baumgartner I., et al. Novel cell-free strategy for therapeutic angiogenesis: in vitro generated conditioned medium can replace progenitor cell transplantation. PLoS One 2009, 4:e5643.
23. Aplin A.C., Fogel E., Zorzi P., Nicosia R.F. The aortic ring model of angiogenesis. Methods Enzymol 2008, 443:119-136.
24. Banerjee M., Bhonde R.R. Application of hanging drop technique for stem cell differentiation and cytotoxicity studies. Cytotechnology 2006, 51:1-5.
25. Amos P.J., Kapur S.K., Stapor P.C., Shang H., Bekiranov S., Khurgel M., et al. Human adipose-derived stromal cells accelerate diabetic wound healing: impact of cell formulation and delivery. Tissue Eng Part A 2010, 16:1595-1606.
26. Couffinhal T., Silver M., Zheng L.P., Kearney M., Witzenbichler B., Isner J.M. Mouse model of angiogenesis. Am J Pathol 1998, 152:1667-1679.
27. Yang F., Cho S.W., Son S.M., Bogatyrev S.R., Singh D., Green J.J., et al. Genetic engineering of human stem cells for enhanced angiogenesis using biodegradable polymeric nanoparticles. Proc Natl Acad Sci U S A 2010, 107:3317-3322.
28. Yoon C.H., Hur J., Park K.W., Kim J.H., Lee C.S., Oh I.Y., et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 2005, 112:1618-1627.
29. Brederlau A., Correia A.S., Anisimov S.V., Elmi M., Paul G., Roybon L., et al. Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells 2006, 24:1433-1440.
30. Tabar V., Panagiotakos G., Greenberg E.D., Chan B.K., Sadelain M., Gutin P.H., et al. Migration and differentiation of neural precursors derived from human embryonic stem cells in the rat brain. Nat Biotechnol 2005, 23:601-606.
31. Tongers J., Roncalli J.G., Losordo D.W. Therapeutic angiogenesis for critical limb ischemia: microvascular therapies coming of age. Circulation 2008, 118:9-16.
32. Lazarous D.F., Unger E.F., Epstein S.E., Stine A., Arevalo J.L., Chew E.Y., et al. Basic fibroblast growth factor in patients with intermittent claudication: results of a phase I trial. J Am Coll Cardiol 2000, 36:1239-1244.
33. Nikol S. Therapeutic angiogenesis for peripheral artery disease: gene therapy. Vasa 2007, 36:165-173.
34. Isner J.M., Feldman L.J. Gene therapy for arterial disease. Lancet 1994, 344:1653-1654.
35. Yla-Herttuala S., Alitalo K. Gene transfer as a tool to induce therapeutic vascular growth. Nat Med 2003, 9:694-701.
36. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
37. Gore A., Li Z., Fung H.L., Young J.E., Agarwal S., Antosiewicz-Bourget J., et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 2011, 471:63-67.
38. Drukker M., Katz G., Urbach A., Schuldiner M., Markel G., Itskovitz-Eldor J., et al. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci U S A 2002, 99:9864-9869.
39. Li L., Baroja M.L., Majumdar A., Chadwick K., Rouleau A., Gallacher L., et al. Human embryonic stem cells possess immune-privileged properties. Stem Cells 2004, 22:448-456.
40. Taylor C.J., Bolton E.M., Pocock S., Sharples L.D., Pedersen R.A., Bradley J.A. Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching. Lancet 2005, 366:2019-2025.
41. Nakajima F., Tokunaga K., Nakatsuji N. Human leukocyte antigen matching estimations in a hypothetical bank of human embryonic stem cell lines in the Japanese population for use in cell transplantation therapy. Stem Cells 2007, 25:983-985.